Akebia Therapeutics, Inc. - Common Stock (AKBA)
CUSIP: 00972D105
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 263,222,327
- Total 13F shares
- 50,244,290
- Share change
- -1,627,429
- Total reported value
- $45,972,433
- Put/Call ratio
- 43%
- Price per share
- $0.92
- Number of holders
- 76
- Value change
- -$1,392,343
- Number of buys
- 29
- Number of sells
- 27
Quarterly Holders Quick Answers
What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00972D105:
Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Alerce Investment Management, L.P. |
13F
|
Company |
6.2%
|
16,205,119
|
$9,081,349 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.8%
|
12,510,904
|
$7,011,110 | — | 31 Mar 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
2.8%
|
7,483,053
|
$4,192,000 | — | 31 Mar 2023 | |
| MIRABELLA FINANCIAL SERVICES LLP |
13F
|
Company |
0.05%
|
140,604
|
$1,831,025 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1%
|
2,703,523
|
$1,515,055 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.89%
|
2,338,500
|
$1,310,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.64%
|
1,682,498
|
$942,871 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.46%
|
1,198,724
|
$671,765 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.39%
|
1,020,032
|
$571,218 | — | 31 Mar 2023 | |
| David A. Spellman |
3/4/5
|
SVP, CFO and Treasurer |
—
class O/S missing
|
446,483
|
$546,004 | — | 16 May 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.35%
|
910,958
|
$511,000 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.26%
|
692,836
|
$388,265 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
644,117
|
$360,962 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0.23%
|
613,590
|
$343,856 | — | 31 Mar 2023 | |
| Violetta Cotreau |
3/4/5
|
SVP, Chief Accounting Officer |
—
class O/S missing
|
219,954
|
$268,982 | — | 12 May 2022 | |
| Dell J. Faulkingham |
3/4/5
|
SVP, CCO |
—
mixed-class rows
|
373,841
mixed-class rows
|
$212,590 | — | 28 Feb 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.14%
|
372,458
|
$208,726 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
371,514
|
$208,196 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.12%
|
302,977
|
$169,788 | — | 31 Mar 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.1%
|
265,267
|
$148,656 | — | 31 Mar 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.1%
|
257,744
|
$144,440 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.08%
|
218,349
|
$122,363 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
193,459
|
$108,337 | — | 31 Mar 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.07%
|
188,818
|
$105,812 | — | 31 Mar 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.06%
|
148,681
|
$83,000 | — | 31 Mar 2023 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.05%
|
142,274
|
$80,000 | — | 31 Mar 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.05%
|
138,037
|
$77,356 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.04%
|
105,500
|
$60,000 | — | 31 Mar 2023 | |
| Michael Thomas Heffernan |
3/4/5
|
Director |
—
mixed-class rows
|
68,686
mixed-class rows
|
$59,416 | — | 02 Jun 2021 | |
| Virtu Financial LLC |
13F
|
Company |
0.04%
|
97,854
|
$55,000 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
87,975
|
$49,266 | — | 31 Mar 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.03%
|
82,473
|
$46,218 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
81,547
|
$45,000 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
79,804
|
$44,722 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
71,836
|
$40,257 | — | 31 Mar 2023 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.03%
|
70,350
|
$40,000 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
67,844
|
$38,020 | — | 31 Mar 2023 | |
| Orchard Capital Management, LLC |
13F
|
Company |
0.03%
|
66,826
|
$37,449 | — | 31 Mar 2023 | |
| EDMOND DE ROTHSCHILD HOLDING S.A. |
13F
|
Company |
0.02%
|
50,000
|
$28,020 | — | 31 Mar 2023 | |
| Icon Wealth Partners, LLC |
13F
|
Company |
0.02%
|
50,000
|
$28,020 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
46,193
|
$25,886 | — | 31 Mar 2023 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.02%
|
41,415
|
$23,209 | — | 31 Mar 2023 | |
| CWA Asset Management Group, LLC |
13F
|
Company |
0.01%
|
29,000
|
$16,252 | — | 31 Mar 2023 | |
| LPL Financial LLC |
13F
|
Company |
0.01%
|
28,596
|
$16,025 | — | 31 Mar 2023 | |
| James J. Burns & Company, LLC |
13F
|
Company |
0.01%
|
25,142
|
$14,000 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
22,895
|
$13,000 | — | 31 Mar 2023 | |
| WEALTH EFFECTS LLC |
13F
|
Company |
0.01%
|
18,316
|
$10,264 | — | 31 Mar 2023 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0.01%
|
14,000
|
$7,885 | — | 31 Mar 2023 | |
| B. Riley Wealth Advisors, Inc. |
13F
|
Company |
0%
|
13,000
|
$7,285 | — | 31 Mar 2023 | |
| Onyx Bridge Wealth Group LLC |
13F
|
Company |
0%
|
12,500
|
$7,005 | — | 31 Mar 2023 |
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2023
As of 30 Jun 2023,
Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,244,290 shares.
The largest 10 holders included
Alerce Investment Management, L.P., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, FEDERATED HERMES, INC., and VICTORY CAPITAL MANAGEMENT INC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
62
Q2 2023 holders
76
Holder diff
14
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.